Cancer Progress

2015Presentations


2015 Sponsors:
Cancer Progress 2015 Sponsors

Tekeda Oncology Symphogen Novartis Oncology Torreya Partners AstraZeneca Pfizer Biothera nanoString

We look forward to seeing you at the 26th Annual Cancer Progress Conference on March 17-18 at the Grand Hyatt
New York in New York City!


Cancer Progress

Since 1985, Cancer Progress is the only oncology conference that invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. Pivotal topics, frank discussions, vigorous debate, lively audience participation and generous networking throughout the meeting during breaks, luncheons, reception and dinner combine to make this a highly impactful conference.

Our 26th Annual Meeting on March 17-18, 2015 will  provide an unsurpassed learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference. Confirmed speakers as of March 13st, 2015 are:

  • Ada Braun, MD, PhD, Biothera
  • Omar Abdel-Wahab, MD, Memorial Sloan Kettering Cancer Center
  • Peter C. Adamson, MD, The Children’s Hospital of Philadelphia
  • Peter Bach, MD, Memorial Sloan-Kettering Cancer Center
  • Robert A. Beckman, MD, Daiichi Sankyo Pharmaceutical
  • Jean-Pierre Bizzari, MD, Celgene Corporation
  • Jeff Bockman, PhD, Defined Health
  • Otis Webb Brawley, MD, FACP, American Cancer Society
  • Renier J. Brentjens, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Lynda Chin, MD, MD Anderson Cancer Center
  • Meredith K. Chuk, MD, FDA
  • Robert Cohen, MD, Calico Life Sciences
  • Barbara A. Conley, MD, NIH, Division of Cancer Treatment and Diagnosis
  • Louis J. DeGennaro, PhD, Leukemia & Lymphoma Society
  • Thomas O. Daniel, MD, Celgene Corporation
  • Kathleen A. Denis, PhD, The Rockefeller University
  • Kapil Dhingra, MD, KAPital Consulting LLC
  • James H. Doroshow, MD, National Cancer Institute
  • Thomas J. Farrell, Bellicum Pharmaceuticals
  • Sean Ferree, PhD, NanoString Technologies
  • Stanley R. Frankel, MD, Columbia University College of Physicians and Surgeons
  • Richard Brian Gaynor, MD, Eli Lilly and Company
  • Jeremy P. Goldberg, JPG Healthcare LLC
  • Brad Gray, NanoStrings Technologies
  • William Grossman, MD, PhD, AbbVie
  • Ivan Horak, MD, Symphogen A/S
  • Axel Hoos, MD, PhD, GlaxoSmithKline
  • Johanna Joyce, PhD, Memorial Sloan Kettering Cancer Center
  • Thomas J. Kipps, MD, PhD, Moores UCSD Cancer Center
  • Michael Kolodziej, MD, Aetna
  • Amy Krie, MD, Avera Cancer Institute
  • Manfred Lehnert, MD, Takeda Pharmaceuticals International
  • Christoph Lengauer, MD, PhD, Blueprint Medicines
  • Hy Levitsky, MD, Roche Pharmaceuticals
  • Brian Leyland-Jones, MD, Avera Cancer Institute
  • Nils Lonberg, PhD, Bristol-Myers Squibb
  • Patricia LoRusso, DO, Smilow Cancer Center, Yale University
  • Ronnie Morris, MD, Champions Oncology
  • Lee Newcomer, MD, MHA, United Healthcare
  • Larry Norton, MD, Memorial Sloan Kettering Cancer Center
  • Louise M. Perkins, PhD, Melanoma Research Alliance
  • Mike Rice, MS, MBA, Defined Health
  • Dr. Harlan Robins, PhD, Adaptive Biotechnologies
  • Carlos Rodriguez-Galindo, MD, Harvard Medical School
  • Noemi Rosa, Novartis
  • Neal Rosen, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Eric Rowinsky, MD, Stemline Therapeutics
  • Rob Ruijtenbeek, PhD, PamGene BV
  • Haleh Saber, PhD, PARAEXEL International
  • Leonard Saltz, MD, Memorial Sloan Kettering Cancer Center
  • Nathan P. Sanburn, Eli Lilly and Company
  • Peter Sandor, MD, MBA, Amgen, Inc.
  • Guarav Shah, MD, Novartis
  • Prof. Dolores J. Schendel, PhD, Medigene
  • Cecelia Schott, Pharm D, MBA, AstraZeneca
  • Jeffrey Settleman, PhD, Genetech
  • Ellen V. Sigal, PhD, Friends of Cancer Research
  • Mark J. Simon, Torreya Partners LLC
  • Eric Slosberg, PhD, Novartis Oncology
  • John J. Sninsky, PhD, Quest Diagnostics
  • David Solit, MD, Memorial Sloan Kettering Cancer Center
  • Marc Theoret, MD, FDA
  • Jedd Wolchok, MD, PhD, Memorial Sloan-Kettering Cancer Center
  • Cassian Yee MD, MD Anderson Cancer Center
  • Maoxia Zheng, PhD, Genentech

We look forward to seeing you at the 26th Annual Cancer Progress Conference on March17-18 at the Grand Hyatt New York in New York City!